Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience.
Valkema R, De Jong M, Bakker WH, Breeman WA, Kooij PP, Lugtenburg PJ, De Jong FH, Christiansen A, Kam BL, De Herder WW, Stridsberg M, Lindemans J, Ensing G, Krenning EP.
Valkema R, et al. Among authors: kooij pp.
Semin Nucl Med. 2002 Apr;32(2):110-22. doi: 10.1053/snuc/2002.31025.
Semin Nucl Med. 2002.
PMID: 11965606
Clinical Trial.